Treating Sleep Apnea Induced Hypoxemia With Oxygen in Acute Stroke Patients
NCT ID: NCT03300063
Last Updated: 2021-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6 participants
INTERVENTIONAL
2018-04-03
2020-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Obstructive Sleep Apnea Treatment From Acute to Chronic Phase of Stroke
NCT07044830
Sleep for Stroke Management and Recovery Trial
NCT03812653
Continuous Positive Airway Pressure on Acute Stroke and Obstructive Sleep Apnea
NCT04458779
Screening and Treatment of SAHS in Patients With Acute Ischemic Stroke
NCT02029183
Continuous Positive Airway Pressure for the Treatment of Stroke
NCT00368628
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control
Standard Medical care
No interventions assigned to this group
Low Flow Nocturnal Oxygen
This group will receive standard medical care as well as low flow oxygen during sleep.
Low flow nocturnal oxygen
Nocturnal low-flow oxygen via nasal cannula
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low flow nocturnal oxygen
Nocturnal low-flow oxygen via nasal cannula
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Melissa Lipford
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Melissa C Lipford
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-002975
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.